Indeed, FLT3L-induced bone marrow dendritic cells were able to partially overcome CTNNB1-driven resistance to T-cell infiltration in melanoma.30 Future work with longer-term DC vaccination may prove useful in circumventing T-cell exclusion driven by CTNNB1 in ACT. The gene discussed is CTNNB1; the disease is melanoma.